{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T15:15:00Z","timestamp":1777994100741,"version":"3.51.4"},"reference-count":32,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Drug overdose is a leading cause of death among US veterans with homeless experience. Medications for opioid use disorder (MOUD) reduce overdose and all-cause mortality, yet receipt remains low among veterans with homeless experience. Identifying factors associated with MOUD receipt in Department of Veterans Affairs (VA) permanent supportive housing (PSH) can inform strategies to support MOUD implementation and advance health equity.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To identify demographic, clinical, and service-related factors associated with MOUD receipt among veterans with homeless experience with opioid use disorder (OUD) in the Housing and Urban Development\u2013VA Supportive Housing (HUD-VASH) program.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n \n This cohort study used linked national VA administrative and electronic health record data. US veterans with OUD entering HUD-VASH between October 1, 2017, and September 30, 2021, were followed up for 12 months after move-in. Eligible participants were diagnosed with OUD as defined by\n International Statistical Classification of Diseases and Related Health Problems, Tenth Revision<\/jats:italic>\n criteria within 5 years before or 1 year after move-in. Sequential logistic regression models examined associations between demographic, clinical, and service utilization factors and MOUD receipt. Statistical analyses were conducted between May 2025 and February 2026.\n <\/jats:p>\n <\/jats:sec>\n \n Exposure<\/jats:title>\n Demographic, clinical, and service-related factors.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n Receipt of MOUD (buprenorphine, methadone, or extended-release naltrexone) within 12 months after HUD VASH move-in.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Among 10\u202f110 veterans with OUD, the mean (SD) age was 53.2 (12.0) years (9297 male [92%]; 3211 Black [32%], 606 Hispanic [6%], 5537 White [55%]); 1685 veterans (17%) received MOUD. Older age (age 55 to 64 years: adjusted odds ratio [AOR], 0.52 [0.42-0.64]) and non-Hispanic Black race (AOR, 0.47 [95% CI, 0.40-0.55]) were associated with lower odds of MOUD receipt, while depression (AOR, 1.24 [95% CI, 1.05-1.46]) and greater behavioral health engagement was associated with higher odds of receipt. Having 1 or more instances of inpatient hospitalization was associated with lower odds of MOUD receipt (AOR, 0.74 [95% CI, 0.64-0.87]).<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this cohort study of veterans with homeless experience with OUD, 1 in 6 veterans received MOUD within a year of entering PSH. Lower rates of MOUD receipt among older veterans and veterans from racial minority groups highlighted persistent inequities, regardless of housing status.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2026.10831","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T15:00:34Z","timestamp":1777993234000},"page":"e2610831","source":"Crossref","is-referenced-by-count":0,"title":["Access to Medications for Opioid Use Disorder Among Veterans With Homeless Experience in Permanent Supportive Housing"],"prefix":"10.1001","volume":"9","author":[{"given":"Michael","family":"Hsu","sequence":"first","affiliation":[{"name":"Veterans Affairs Greater Los Angeles Health Care, Los Angeles, California"},{"name":"Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Talia","family":"Panadero","sequence":"additional","affiliation":[{"name":"Veterans Affairs Greater Los Angeles Health Care, Los Angeles, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larissa J.","family":"Mooney","sequence":"additional","affiliation":[{"name":"Veterans Affairs Greater Los Angeles Health Care, Los Angeles, California"},{"name":"Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Lawrence","sequence":"additional","affiliation":[{"name":"Veterans Affairs Greater Los Angeles Health Care, Los Angeles, California"},{"name":"David Geffen School of Medicine, University of California, Los Angeles"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"Yuan","sequence":"additional","affiliation":[{"name":"Veterans Affairs Greater Los Angeles Health Care, Los Angeles, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prabha","family":"Siddarth","sequence":"additional","affiliation":[{"name":"David Geffen School of Medicine, University of California, Los Angeles"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonya","family":"Gabrielian","sequence":"additional","affiliation":[{"name":"Veterans Affairs Greater Los Angeles Health Care, Los Angeles, California"},{"name":"David Geffen School of Medicine, University of California, Los Angeles"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","published-online":{"date-parts":[[2026,5,5]]},"reference":[{"issue":"2","key":"zoi260331r1","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1111\/add.16689","article-title":"Drug overdose deaths among homeless veterans in the United States Department of Veterans Affairs healthcare system.","volume":"120","author":"Tsai","year":"2025","journal-title":"Addiction"},{"issue":"2","key":"zoi260331r2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.20622","article-title":"Comparative effectiveness of different treatment pathways for opioid use disorder.","volume":"3","author":"Wakeman","year":"2020","journal-title":"JAMA Netw Open"},{"key":"zoi260331r3","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2022.109445","article-title":"Systematic review and meta-analysis of changes in quality of life following initiation of buprenorphine for opioid use disorder.","volume":"235","author":"Golan","year":"2022","journal-title":"Drug Alcohol Depend"},{"issue":"19","key":"zoi260331r4","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1056\/NEJMsa2212412","article-title":"Racial inequality in receipt of medications for opioid use disorder.","volume":"388","author":"Barnett","year":"2023","journal-title":"N Engl J Med"},{"issue":"8","key":"zoi260331r5","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1377\/hlthaff.2019.00281","article-title":"Comparative effectiveness of different treatment pathways for opioid use disorder.","volume":"38","author":"Midboe","year":"2019","journal-title":"Health Aff"},{"key":"zoi260331r6","doi-asserted-by":"publisher","DOI":"10.1016\/j.josat.2023.209216","article-title":"Access challenges to opioid use disorder treatment among individuals experiencing homelessness: voices from the streets.","volume":"157","author":"Hsu","year":"2024","journal-title":"J Subst Use Addict Treat"},{"issue":"6","key":"zoi260331r8","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.17103","article-title":"Modeling health and economic outcomes of providing stable housing to homeless adults with OUD.","volume":"8","author":"Rao","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"9","key":"zoi260331r9","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1001\/jamapsychiatry.2019.0876","article-title":"Buprenorphine treatment divide by race\/ethnicity and payment.","volume":"76","author":"Lagisetty","year":"2019","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"zoi260331r10","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-080678","article-title":"How far back do we need to look to capture diagnoses in electronic health records? A retrospective observational study of hospital electronic health record data.","volume":"14","author":"Lewis","year":"2024","journal-title":"BMJ Open"},{"key":"zoi260331r11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/CLEP.S181242","article-title":"Measuring prevalence and incidence of chronic conditions in claims and electronic health record databases.","volume":"11","author":"Rassen","year":"2018","journal-title":"Clin Epidemiol"},{"issue":"3","key":"zoi260331r12","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1037\/ser0000561","article-title":"Healthcare service utilization for formerly homeless veterans in permanent supportive housing: do neighborhoods matter?","volume":"19","author":"Wong","year":"2022","journal-title":"Psychol Serv"},{"issue":"8","key":"zoi260331r13","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1377\/hlthaff.2019.00281","article-title":"The opioid epidemic in veterans who were homeless or unstably housed.","volume":"38","author":"Midboe","year":"2019","journal-title":"Health Aff (Millwood)"},{"issue":"2","key":"zoi260331r14","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1093\/pm\/pnaf116","article-title":"Evidence-based framework for identifying opioid use disorder in administrative data: a systematic review and methodological development study.","volume":"27","author":"Hurley","year":"2026","journal-title":"Pain Med"},{"issue":"1","key":"zoi260331r16","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","article-title":"Comorbidity measures for use with administrative data.","volume":"36","author":"Elixhauser","year":"1998","journal-title":"Med Care"},{"issue":"2S Suppl 1","key":"zoi260331r17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/ADM.0000000000000633","article-title":"The ASAM national practice guideline for the treatment of opioid use disorder: 2020 focused update.","volume":"14","author":"American Society of Addiction Medicine Focused Update Guideline Committee","year":"2020","journal-title":"J Addict Med"},{"issue":"6","key":"zoi260331r18","first-page":"1273","article-title":"The Behavioral Model for Vulnerable Populations: application to medical care use and outcomes for homeless people.","volume":"34","author":"Gelberg","year":"2000","journal-title":"Health Serv Res"},{"issue":"2","key":"zoi260331r19","doi-asserted-by":"publisher","first-page":"284","DOI":"10.2105\/AJPH.2021.306577","article-title":"Self-reported treatment need and barriers to care for adults with opioid Use disorder: the US national survey on drug use and health, 2015 to 2019.","volume":"112","author":"Saini","year":"2022","journal-title":"Am J Public Health"},{"key":"zoi260331r20","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.drugalcdep.2018.12.030","article-title":"Co-occurring substance use and mental disorders among adults with opioid use disorder.","volume":"197","author":"Jones","year":"2019","journal-title":"Drug Alcohol Depend"},{"issue":"24","key":"zoi260331r21","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1056\/NEJMra1805981","article-title":"Substance-use disorders in later life.","volume":"379","author":"Lehmann","year":"2018","journal-title":"N Engl J Med"},{"key":"zoi260331r22","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jsat.2016.07.011","article-title":"Staff perceptions of substance use disorder treatment in VA primary care-mental health integrated clinics.","volume":"70","author":"Zubkoff","year":"2016","journal-title":"J Subst Abuse Treat"},{"issue":"1","key":"zoi260331r23","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40352-025-00336-6","article-title":"Receipt of medications for opioid use disorders among veterans by race\/ethnicity and legal involvement: an observational study of electronic health records.","volume":"13","author":"Finlay","year":"2025","journal-title":"Health Justice"},{"issue":"3","key":"zoi260331r24","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1097\/ADM.0000000000001275","article-title":"Buprenorphine receipt and retention for opioid use disorder following an initiative to increase access in primary care.","volume":"18","author":"Hawkins","year":"2024","journal-title":"J Addict Med"},{"key":"zoi260331r25","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2025.112764","article-title":"Sex and race-ethnicity influences on opioid overdose deaths among veterans diagnosed with opioid use disorder between 2016 and 2021.","volume":"274","author":"Mandavia","year":"2025","journal-title":"Drug Alcohol Depend"},{"issue":"12","key":"zoi260331r26","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.2105\/AJPH.2016.303483","article-title":"Is the prescription opioid epidemic a white problem?","volume":"106","author":"Hansen","year":"2016","journal-title":"Am J Public Health"},{"issue":"Suppl 2","key":"zoi260331r27","doi-asserted-by":"publisher","DOI":"10.1111\/1475-6773.14371","article-title":"Engaging healthcare teams to increase access to medications for opioid use disorder.","volume":"59","author":"Oberman","year":"2024","journal-title":"Health Serv Res"},{"issue":"3","key":"zoi260331r28","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1080\/08897077.2020.1787299","article-title":"Stepped Care for Opioid Use Disorder Train the Trainer (SCOUTT) initiative: expanding access to medication treatment for opioid use disorder within Veterans Health Administration facilities.","volume":"41","author":"Gordon","year":"2020","journal-title":"Subst Abus"},{"issue":"12","key":"zoi260331r29","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.37238","article-title":"Accessibility to medication for opioid use disorder after interventions to improve prescribing among nonaddiction clinics in the US veterans health care system.","volume":"4","author":"Hawkins","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"2","key":"zoi260331r30","doi-asserted-by":"publisher","DOI":"10.1093\/haschl\/qxae007","article-title":"Navigating addiction treatment during COVID-19: policy insights from state health leaders.","volume":"2","author":"White","year":"2024","journal-title":"Health Aff Sch"},{"issue":"11","key":"zoi260331r31","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.43543","article-title":"Buprenorphine treatment for opioid use disorder in non-addiction specialty settings.","volume":"8","author":"Huebler","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"1","key":"zoi260331r32","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/add.16338","article-title":"Identifying patients with opioid use disorder using International Classification of Diseases (ICD) codes: challenges and opportunities.","volume":"119","author":"Osterhage","year":"2024","journal-title":"Addiction"},{"key":"zoi260331r7","unstructured":"National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Population Health and Public Health Practice, Policy and Global Affairs, Science and Technology for Sustainability Program, Committee on an Evaluation of Permanent Supportive Housing Programs for Homeless Individuals. Permanent supportive housing: evaluating the evidence for improving health outcomes among people experiencing chronic homelessness. National Academies of Sciences, Engineering, and Medicine consensus study report. Published online 2018. Accessed September 5, 2025. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK519594\/"},{"key":"zoi260331r15","unstructured":"Centers for Medicare & Medicaid Services. Billing and coding: opioid treatment programs (A59718). Published online October 20, 2024. Accessed October 8, 2025. https:\/\/localcoverage.cms.gov\/mcd_archive\/view\/article.aspx?articleInfo=59718:4"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2848609\/hsu_2026_oi_260331_1777322739.71853.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T15:00:37Z","timestamp":1777993237000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2848609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,5]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.10831","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,5]]}}}